Event JSON
{
"id": "30c5b59ea997e956be80479208e81a2e39e8ee91ca3bc865d2d03f4924229c1a",
"pubkey": "bd200f91f5f6f2d94b71e5c179a3291de2d6eb025724518b8f0f1356117e4d21",
"created_at": 1738167226,
"kind": 1,
"tags": [
[
"imeta",
"url https://amicale.net/system/media_attachments/files/113/912/527/020/680/951/original/c7d60b56c975985c.jpg",
"m image/jpeg"
],
[
"proxy",
"https://amicale.net/@reuters/113912527350529155",
"web"
],
[
"proxy",
"https://amicale.net/users/reuters/statuses/113912527350529155",
"activitypub"
],
[
"L",
"pink.momostr"
],
[
"l",
"pink.momostr.activitypub:https://amicale.net/users/reuters/statuses/113912527350529155",
"pink.momostr"
],
[
"-"
]
],
"content": "Teva Pharm tops quarterly estimates but 2025 earnings outlook falls short https://www.reuters.com/business/healthcare-pharmaceuticals/teva-pharm-q4-tops-estimates-strong-sales-its-own-drugs-2025-01-29/?taid=679a4d04a56d86000131e440\u0026utm_medium=Social\u0026utm_source=Mastodon\nhttps://amicale.net/system/media_attachments/files/113/912/527/020/680/951/original/c7d60b56c975985c.jpg\n",
"sig": "233528444bb8747af920b500671e8f3b62969069b20c79507e5b41d18dbdf26f63993359aac7c6d54ad6442bec1ce5302af0bdcbd13fe9266709c7b13c50599d"
}
